Tim Considine

Tim Considine is currently a corporate development advisor at Model Medicines. Prior to this, they served as the Chief Operating Officer at Known Medicine from September 2020 to September 2021. Tim's work there focused on finding the best treatment for every cancer patient. From November 2019 to September 2020, they served as the Chief Strategy Officer at Nuritas, providing commercial litigation counsel to a wide variety of industries.

From April 2015 to October 2019, Tim was the Senior Vice President of Strategic Development at Recursion Pharmaceuticals, where they led clinical development activities for cell therapy in neurodegenerative diseases. From August 2014 to October 2015, they served as the Vice President of Clinical Operations at Q Therapeutics, Inc., again leading clinical development activities for cell therapy in neurodegenerative diseases.

Tim has also been a Principal at Considine Comprehensive Consulting and C3 Consulting, LLC, and an attorney at Manning Curtis Bradshaw & Bednar and Stoel Rives LLP.

The educational career for Tim Considine would include a J.D. from the University of Utah S.J. Quinney College of Law, a B.Sc. (Hons.) in Pharmacology from University College Dublin, and a Statistics in Medicine from Stanford University School of Medicine.